Clinical Trial Update: Ferric Carboxymaltose in Subjects With Functional Iron Deficiency Undergoing Chemotherapy [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating ferric carboxymaltose for functional iron deficiency in patients undergoing chemotherapy has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Iron Deficiency Anemia

Drugs mentioned

• Ferric carboxymaltose (ferric carboxymaltose)

Snippet

Sponsor: Vifor Pharma | Conditions: Iron-Deficiency Anemia | Phase 3 | Status: COMPLETED